8-K
filed December 4, 2023, 6:59 PM ET
ticker SILO
CIK 0001514183
other material
confidence high
sentiment neutral
materiality 0.15
Silo Pharma shareholders approve 80% authorized share reduction and equity plan at annual meeting
Silo Pharma, Inc.
- Four directors elected: Weisblum, Linsley, Muñoz, Pavell (1.45M-1.45M for each).
- Amended 2020 Omnibus Equity Incentive Plan approved (1.43M for, 97,553 against, 11,988 abstain).
- Authorized common shares reduced from 500M to 100M (1.52M for, 2,648 against, 10,000 abstain).
- Ratification of Salberg & Company as auditor approved (1.51M for, 189 against, 66,435 abstain).
- Vote on reincorporation to Nevada adjourned to December 11, 2023; results to be filed later.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Silo Pharma, Inc. shareholders approved Election of four directors at the 2023-12-04 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-12-04
Exact text from the filing
The result of the votes to elect the four directors was as follows: Directors For Withheld Broker Non-Votes Eric Weisblum 1,448,375 88,266 40,875 Wayne D. Linsley 1,406,716 129,925 40,875 Dr. Kevin Muñoz 1,422,577 114,064 40,875 Dr. Jeff Pavell 1,448,425 88,216 40,875
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Silo Pharma, Inc. shareholders approved Amendment to Certificate of Incorporation to decrease authorized shares from 500,000,000 to 100,000,000 at the 2023-12-04 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2023-12-04
Exact text from the filing
The result of the votes to approve the Share Decrease Proposal was as follows: For Against Abstain Broker Non-Vote 1,523,993 2,648 10,000 40,875
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Silo Pharma, Inc. shareholders approved Ratification of appointment of Salberg & Company, P.A. as independent public accountant at the 2023-12-04 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-04
Exact text from the filing
The result of the votes to approve Salberg & Company, P.A. was as follows: For Against Abstain 1,510,892 189 66,435
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Silo Pharma, Inc. shareholders approved Approval of Amended and Restated 2020 Omnibus Equity Incentive Plan at the 2023-12-04 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-12-04
Exact text from the filing
The result of the votes to approve the Amended 2020 Plan was as follows: For Against Abstain Broker Non-Vote 1,427,100 97,553 11,988 40,875
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.